On Thursday 24th June, Neuro-Bio Ltd. hosted a virtual Shareholders’ Showcase Presentation and Discussion with UK and Australia. The event enabled the Neuro-Bio team the chance to share with the audience the exciting progress already achieved by the company, and to...
We would like to formally welcome our new Lab manager – Sarah Berrido! Sarah’s previous experience working in Hard-Goods & Food manufacturing has developed her knowledge of Legal compliance, supply chain limitations & the development, monitoring...
Recently, our CEO and Founder Baroness Susan Greenfield sat with Tom Froggatt and discussed, among many other things, what makes Neuro-Bio Ltd different and why our approaches are so novel. Susan was a guest on Careers in Discovery, with Tom Froggatt and they explored...
NEURO-BIO LTD HAS BEEN GRANTED A TECNIOSPRING INDUSTRY AWARD 2021 Neuro-Bio has been awarded a Tecniospring INDUSTRY award together with the Catalan CRO, Xenopat (www.xenopat.com ) to develop a new antitumor drug and / or antimetastatic drug based on the inhibition of...
We are delighted to announce Rosie and James have accepted their offers to continue their work with Neuro-Bio for 3 more months! Here’s their thoughts about the extension: “I am thrilled to have extended my time at Neuro-Bio for an extra three months! I...
Neuro-bio announces a collaboration with Professor Zoltán Molnár and Auguste Vadisiute. Auguste is a DPhil student at Christ Church College at the University of Oxford (Department of Physiology, Anatomy and Genetics) and is studying the role of microglia in...
